Research Topic · Peer-Reviewed

Cancer Prevention

Cancer prevention encompasses the strategies, interventions, and behaviors that reduce the probability of developing malignant disease or detect premalignant change early enough to interrupt carcinogenesis. It is conventionally divided into primary prevention (removing or mitigating causative exposures such as tobac…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 121× across the literature 🔖 ISSN 2639-1716 🗓 Reviewed July 2026

Overview

Cancer prevention encompasses the strategies, interventions, and behaviors that reduce the probability of developing malignant disease or detect premalignant change early enough to interrupt carcinogenesis. It is conventionally divided into primary prevention (removing or mitigating causative exposures such as tobacco, certain infections, and dietary or occupational carcinogens), secondary prevention (screening and treatment of precursor lesions before invasive cancer arises), and tertiary prevention (limiting recurrence and second primaries). Chemoprevention, the use of pharmacologic or natural agents to suppress, arrest, or reverse the molecular events underlying tumor initiation and promotion, is a central theme, alongside vaccination against oncogenic pathogens and modifiable lifestyle factors. Work published in this area examines pharmacologic chemoprevention, including the role of nonsteroidal anti-inflammatory drugs in colorectal cancer and statins in lung cancer, as well as cervical cancer screening uptake and awareness across diverse populations, complementary and alternative approaches, and the antioxidant and phytochemical properties of dietary plant constituents relevant to risk reduction. The breadth of populations and mechanisms reflected here, from cyclooxygenase modulation to community-level screening behavior, underscores that effective prevention integrates molecular pharmacology, epidemiology, and public-health practice. The journal publishes peer-reviewed research addressing these prevention modalities and their underlying biology.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

The Role of Heparin in Lung Cancer

Abu Arab WalidCorresponding author
Service de Chirurgie thoracique, Université de Sherbrooke, Québec, Canada
Neoplasms Cited by 7 doi:10.14302/issn.2639-1716.jn-17-1499
2024

A Study on Nutraceuticals

Bajaj ManyaCorresponding author
Exact topic International Journal of Nutrition doi:10.14302/issn.2379-7835.ijn-24-4921

How this research is being cited

The 12 articles above have been cited 121 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cancer Prevention, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Neoplasms (ISSN 2639-1716).

Journal editorial board
Chi Leung CHIANG · Hong Kong Diogo Moura · Portugal Argyrios Tzamalis · Greece

This page summarises published research for orientation; it is not medical or professional advice.